Blog - Page 3071 of 5583

WednesdayJul 11, 2012 8:16 am

Koss Corp. (KOSS) Enters Partnership with Mossy Oak® to Create Three New Headphone Products

Koss, a high fidelity stereophone manufacturer and inventor of the world’s first SP/3 Stereophone in 1958, based in Milwaukee, Wisconsin, announced a partnership with Mossy Oak. The partnership will allow for the combination of Mossy Oak’s award winning patterns and Koss Corporation’s headphones. Specifically, the Break-Up Infinity® and Break-Up® patterns will be applied hydrographically to three unique styles of headphones: a full-size stereophone, an on-ear stereophone, and two sets of earbud stereophones. The Koss KMO20G full size stereophone has been designed specifically to maximize comfort, durability, and performance. Extended frequency response was achieved through the implementation of dynamic elements throughout…

WednesdayJul 11, 2012 8:13 am

Satcon Technology Corp. (SATC) Chosen for One of the Largest Solar PV Power Plants in California

Yesterday, Satcon Technology, a leader in providing utility-scale power conversion solutions for the renewable energy market, announced it has been selected to provide 51 MW of its Equinox Prism Platform solution and 1.5 MW of its next-generation Equinox inverter systems for a solar power plant in Southern California. The Equinox Prism Platform solution is a fully integrated multi-megawatt medium voltage (MV) building block. The installation will be interconnected to the San Diego Gas & Electric (SDGE) grid as a qualified facility for a large generator interconnection agreement (LGIA) under California Independent System Operator Corporation jurisdiction. It will be one of…

TuesdayJul 10, 2012 3:30 pm

A.P. Pharma, Inc. (APPA) Receives 3 Patent Allowances for Lead Candidate APF530

Specialty pharmaceutical company A.P. Pharma today announced that the U.S. Patent and Trademark Office (USPTO) has allowed three new patents covering APF530, the company’s lead product candidate for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV). A.P. Pharma president and CEO John B. Whelan called the patents “instrumental” in augmenting the product’s overall patent life, which will extend through 2024. “A.P. Pharma continues to make advancements related to APF530 beyond clinical and regulatory development, and the allowance of these patents provides added strength to the APF530 patent estate and will help support the product’s longevity,” Whelan…

TuesdayJul 10, 2012 1:35 pm

Gold Standard Ventures Corp. (GSV) Maps Main Mineralization Target at Flagship Property’s Key Site with CSAMT Geophysical Survey

Gold Standard Ventures has accrued a considerable acreage position through the company’s district-scale approach to accumulating mineralized gold acreage in Nevada’s prolific Carlin Trend and reported good news today on the North Bullion Fault Zone at their flagship Railroad Gold Project in Elko County, as the CSAMT (controlled-source audio-frequency magnetotelluric) geophysical survey has outlined the primary target area of high-grade gold mineralization discovered in recent drilling. The CSAMT was done by Zonge International out of Tucson and has delivered encouraging data that looked at some 42% of the over six mile-long North Bullion Fault Zone structural corridor (in 12 lateral…

TuesdayJul 10, 2012 11:05 am

Serious about Trading? Then SeriousTraders is for You!

Our partner SeriousTraders knows that elite traders have to stay on top of the market at all times, and they stand behind them by continually searching for incredible trading opportunities. SeriousTraders is jam packed with informative market data and specialized articles; you won’t miss an opportunity to hone your trading edge. Even if you’re just looking to become a Serious Trader, but don’t know where to begin – look no further. SeriousTraders wants you to feel confident in the news and information they publish. That’s why SeriousTraders is constantly researching and updating their website to bring you the latest information.…

TuesdayJul 10, 2012 11:03 am

Eyes on the Go, Inc. (AXCG) is “One to Watch”

Eyes on the Go provides video and audio systems that enable users to access images over the Internet. In January 2012, the company launched their GANDER.tv web site. This site provides online streaming video and audio targeted to the hospitality industry. With the introduction of GANDER.tv, the company is leveraging their proprietary hardware and software platform to bring streaming video and audio from hospitality venues to consumers. The company has developed a proprietary software program that runs on computer platforms at customers' facilities that streams video images and sound from multiple cameras and microphones, and makes them available to consumers…

TuesdayJul 10, 2012 10:35 am

Duma Energy Corp. (DUMA) Executes Strategic Plan to Achieve Ambitious Goals

Duma Energy has rapidly emerged from a portfolio of domestic hydrocarbon assets which put it in line for a 2013 production target of 2,500 boepd (barrels of oil equivalent per day). This level of production also suggests that Duma Energy is ready to join the international energy game via a number of carefully selected project acquisitions in exceptional return markets. Churning out some 38,000 boe in FY11, with another 45,000 boe in the first half of FY12, DUMA has aggressively applied an operational strategy rooted in a serious financial commitment by the CEO and other insiders which devolves into 75…

TuesdayJul 10, 2012 8:36 am

CytRx Corp. (CYTR) Announces Allowance of US Patent Application

Yesterday, CytRx announced that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application with claims covering a pharmaceutical composition of the drug tamibarotene in capsule form. CytRx is currently conducting a Phase 2b global clinical trial with tamibarotene. CytRx is focused on research and development that specializes in oncology, and currently has three programs in their pipeline that are in clinical development for cancer indications: aldoxorubicin (formerly known as INNO-206), tamibarotene, and bafetinib. Furthermore, CytRX has initiated an international Phase 2b clinical trial as a treatment for soft tissue sarcomas, completed its…

MondayJul 09, 2012 3:45 pm

Advanced Cell Technology, Inc. (ACTC) Receives Data and Safety Monitoring Board Authorization to Proceed with Patient Enrollment

Advanced Cell Technology, a leading player in the field of regenerative medicine, today announced it is now authorized to proceed with enrollment and treatment of additional patients in its clinical trial for dry age-related macular degeneration (dry AMD). The authorization, issued by the Data and Safety Monitoring Board (DSMB), allows ACT to continue patient screening and enrollment for the second cohort, who will be injected with 100,000 retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs), as compared with the 50,000-cell dose used in the first cohort. ACT says the DSMB clearance marks a key achievement for…

MondayJul 09, 2012 11:43 am

Capstone Turbine Corp. (CPST) Receives 2MW Orders for Microturbines, Continued Signs of Expanding Market Position

Capstone Turbine, a top global cleantech manufacturer of low-emission microturbines, (and the first company to deliver a commercially viable microturbine to market) with over 6.5k units shipped worldwide, reported some 2MW worth of orders today from two sizeable domestic hydrocarbon producers, marking yet another set of customers in the oil and gas market to seize upon the benefits of the company’s robust, versatile microturbines for on-site prime power. Once again, trusted CPST distributor Horizon Power Systems can be thanked for diligently working to secure new deals, with the first order (a C1000 Power Package) being a follow-on order from a…

Site Search

Company Search